Evedientes, Jun Mae .
HRN: 23-53-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2024
CEFTRIAXONE 1G (VIAL)
10/11/2024
10/18/2024
IV
900 Mg
Q24 Hrs
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes